rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Inovio Pharmaceuticals, Inc.

INO · Nasdaq

Health CareBiotechnologyNot moving yet

INO stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 42 weeks. It is 16.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 42
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
1
Institutions holding
99 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k8 Sep 2020filed 6 Nov 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders99+5 on the quarter
New · exited26 · 20
Reported value$35.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCreduced · filed 13 Aug 20268,454,797$9.3M-884,817−9.5%
Jupiter Topco LLCnew · filed 14 Aug 20265,171,053$5.7M+5,171,053
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,650,562$4.0M+749,354+25.8%
Boxer Capital Management, LLCadded · filed 14 Aug 20262,844,994$3.1M+474,872+20.0%
ADAR1 Capital Management, LLCadded · filed 14 Aug 20262,143,910$2.4M+673,802+45.8%
D. E. Shaw & Co., Inc.reduced · filed 14 Aug 20261,351,656$1.5M-861,163−38.9%
Stonepine Capital Management, LLCnew · filed 14 Aug 20261,345,237$210K+1,345,237
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 20261,239,778$1.4M+849,394+217.6%
Eversept Partners, LPunchanged · filed 14 Aug 20261,035,360$1.1M00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026802,751$884K+1,247+0.2%
31 Dec 2023 – 30 Jun 2026
85296Dec 23Sep 24Mar 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Ann Calby Miller Company insiderDirector · last 20 May 20260 · 0
David B. Weiner Company insiderDirector · last 20 May 20260 · 18
Jacqueline Elizabeth Shea Company insiderChief Executive Officer · last 20 May 20260 · 6
Jay Shepard Company insiderDirector · last 20 May 20260 · 0
Laurent Humeau Company insiderChief Scientific Officer · last 20 May 20262 · 5
Lota S. Zoth Company insiderDirector · last 20 May 20260 · 5
Michael John Sumner Company insiderChief Medical Officer · last 20 May 20260 · 0
Peter Kies Company insiderCFO · last 20 May 20265 · 10
Roger D. Dansey Company insiderDirector · last 20 May 20260 · 0
Simon X. Benito Company insiderDirector · last 20 May 20262 · 11
Wendy L. Yarno Company insiderDirector · last 20 May 20260 · 0
Jong Joseph Kim Company insiderChief Executive Officer · last 11 Mar 202218 · 13

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 12 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$44.3M
Free cash flowFY 2025 · to 31 Dec 2025−$88.9M

Analyst forecasts

No analyst forecasts yet.